Erratum: Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting

Martina Burlando, Riccardo Castelli, Emanuele Cozzani, Aurora Parodi

The authors wish to make the following corrections to their article:

Burlando M, Castelli R, Cozzani E, Parodi A. Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting. Drugs in Context 2021; 10: 2021-2-6. DOI: 10.7573/dic.2021-2-6

Article Details

Article Type

Erratum

DOI

10.7573/dic.2021-6-8

Original article

Publication Dates

Published: .

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.